Skip to main content

Closed

OCS: Oculis Holding AG Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-16741.0%

ROIC-42.1%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-105.3×

Current ratio5.18×

Oculis Holding AG

OCSNASDAQ Global Market·USD·Closed

Oculis Holding AG

OCSNASDAQ·USD·Closed

$11.31

+0.89%

$11.31

+$0.10 (0.89%)

52W Range

3thpctl

Volume

0.28×avg

Mkt Cap

646.59MUSD

P/E

-5.3TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.28×avg

Market Cap

646.59MUSD

P/E Ratio

-5.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings